Below are the top mid-cap drug manufacturers-other stocks on the NYSE and the NASDAQ in terms of return on assets.
The trailing-twelve-month return on equity at United Therapeutics UTHR is 15.87%. United Therapeutics' operating margin for the same period is 43.33%.
The trailing-twelve-month return on equity at Warner Chilcott plc WCRX is 11.92%. Warner Chilcott's revenue for the same period is $2.45 billion.
The trailing-twelve-month return on equity at Dr. Reddy's Laboratories RDY is 9.82%. Dr. Reddy's PEG ratio is 1.29.
The trailing-twelve-month return on equity at Endo Health Solutions ENDP is 8.04%. Endo Health had $340.52 million in total cash for the latest quarter.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in